Go Pro
→ NASA's ISS Replacement Could Go to This Tiny Space Firm (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$1.87
-4.1%		$2.63
$1.83
▼
$42.00
$6.68M0.4592,071 shs83,937 shs
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$0.00
$2.91
▼
$82.80
$1.90M2.031,362 shs6,500 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.78
-2.7%		$1.63
$1.40
▼
$5.14
$7.90MN/AN/A66,168 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.89
+11.2%		$1.02
$0.02
▼
$1.89
$9.03M1.811,300 shs385 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-4.10%-9.22%-17.62%-73.36%-94.06%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00%0.00%0.00%0.00%0.00%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-2.73%+5.95%+16.34%-4.30%-63.52%
Sonendo, Inc. stock logo
SONX
Sonendo
+11.18%+45.38%+225.86%+215.00%+656.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$1.87
-4.1%		$2.63
$1.83
▼
$42.00
$6.68M0.4592,071 shs83,937 shs
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$0.00
$2.91
▼
$82.80
$1.90M2.031,362 shs6,500 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.78
-2.7%		$1.63
$1.40
▼
$5.14
$7.90MN/AN/A66,168 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.89
+11.2%		$1.02
$0.02
▼
$1.89
$9.03M1.811,300 shs385 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-4.10%-9.22%-17.62%-73.36%-94.06%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00%0.00%0.00%0.00%0.00%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-2.73%+5.95%+16.34%-4.30%-63.52%
Sonendo, Inc. stock logo
SONX
Sonendo
+11.18%+45.38%+225.86%+215.00%+656.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.20
Hold$52.502,707.49% Upside
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.50
Moderate Buy$9.33424.34% Upside
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RSLSD, SINT, ICCM, and SONX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/17/2026
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$3.38M1.90N/AN/A$3.72 per share0.50
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$610K0.00N/A0.08$341.84 per share0.00
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.09M7.09N/AN/A$0.80 per share2.23
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.20N/AN/A$89.42 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$15.06M-$8.52N/AN/AN/A-427.67%-174.26%-112.58%11/18/2026 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
-$81.15MN/AN/AN/AN/A-668.58%-163.22%-52.10%N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$10.36M-$4.91N/AN/AN/A-848.20%-354.44%-115.37%11/11/2026 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$71.12N/AN/AN/A-92.74%-184.01%-68.60%11/11/2026 (Estimated)

Latest RSLSD, SINT, ICCM, and SONX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$0.73-$0.75-$0.02-$0.75$0.46 million$0.45 million
6/30/2026Q2 2026
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/A-$1.60N/A-$1.5970N/A$0.91 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$0.6033.71%N/AN/A N/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/A
2.88
2.44
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.05
1.17
1.07
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
2.36
1.60
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.62%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.44%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
4.08%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
663.43 million3.34 millionNot Optionable
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
50354,000N/ANot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
324.32 million4.14 millionNot Optionable
Sonendo, Inc. stock logo
SONX
Sonendo
2504.78 million393,000Not Optionable

Recent News About These Companies

Sonendo Achieves Milestone of Two Million Patients Treated with the GentleWave® Procedure
September 21 at 6:28 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20260921529965/en/sonendo-achieves-milestone-of-two-million-patients-treated-with-the-gentlewave%c2%ae-procedure/
Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even
August 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260825390808/en/sonendo-announces-key-initiatives-to-drive-business-towards-cashflow-break-even/
Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024
June 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20241029781245/en/Sonendo-Inc.-to-Report-Third-Quarter-2024-Financial-Results-on-November-12-2024
Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga
April 8, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SONX
Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
March 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260316143036/en/sonendo-inc.-on-path-to-breakeven-in-the-second-half-of-2026/
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...
August 22, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer
Sonendo names John McGaugh COO
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sonendo-names-john-mcgaugh-coo/ar-AA1KU4kG
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
August 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer/
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
August 13, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250813720540/en/sonendo-inc.-reports-second-quarter-2025-financial-results-and-reaffirms-financial-guidance/
Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
June 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250604534828/en/Sonendo-Inc.-Reports-First-Quarter-2025-Financial-Results-and-Issues-Financial-Guidance/
Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250326534061/en/sonendo-inc.-reports-fourth-quarter-and-full-year-2024-financial-results/
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
November 11, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241111083660/en/sonendo-inc.-to-release-third-quarter-2024-financial-results-and-postpone-conference-call-on-november-12-2024/
Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
November 5, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2364453/sonendo-inc-sonx-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2364453
Sonendo Launches ProControlTM for the GentleWave® G4 System
October 23, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241023284533/en/sonendo-launches-procontroltm-for-the-gentlewave%c2%ae-g4-system/
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
October 10, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241010657314/en/sonendo-inc.-announces-preliminary-third-quarter-2024-financial-results/
BIOLASE files for Chapter 11, plans asset sale to Sonendo
October 3, 2024  |  investing.comhttps://www.investing.com/news/company-news/biolase-files-for-chapter-11-plans-asset-sale-to-sonendo-3643778
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
August 27, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2327671/here-s-why-sonendo-sonx-is-a-great-buy-the-bottom-stock-now?cid=cs-stocknewsapi-ft-tale_of_the_tape|hammer_chart_pattern_(ta)-2327671
Sonendo Inc.
August 17, 2024  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SONX/financials/secfilings
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
August 10, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4713322-sonendo-inc-sonx-q2-2024-earnings-call-transcript
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
August 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2318510/sonendo-inc-sonx-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2318510

New MarketBeat Followers Over Time

Media Sentiment Over Time

IceCure Medical stock logo

IceCure Medical NASDAQ:ICCM

$1.87 -0.08 (-4.10%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$1.86 -0.01 (-0.53%)
As of 06:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

ReShape Lifesciences stock logo

ReShape Lifesciences OTCMKTS:RSLSD

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Sintx Technologies stock logo

Sintx Technologies NASDAQ:SINT

$1.78 -0.05 (-2.73%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$1.78 +0.00 (+0.28%)
As of 09/23/2026 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Sonendo stock logo

Sonendo NYSE:SONX

$1.89 +0.19 (+11.18%)
As of 09/23/2026 02:09 PM Eastern

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas